These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery. Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers. Deb B; Sengupta P; Sambath J; Kumar P Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033228 [TBL] [Abstract][Full Text] [Related]
24. Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection. Staudt DE; Murray HC; Skerrett-Byrne DA; Smith ND; Jamaluddin MFB; Kahl RGS; Duchatel RJ; Germon ZP; McLachlan T; Jackson ER; Findlay IJ; Kearney PS; Mannan A; McEwen HP; Douglas AM; Nixon B; Verrills NM; Dun MD Clin Proteomics; 2022 Dec; 19(1):48. PubMed ID: 36536316 [TBL] [Abstract][Full Text] [Related]
25. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Kosako H; Nagano K Expert Rev Proteomics; 2011 Feb; 8(1):81-94. PubMed ID: 21329429 [TBL] [Abstract][Full Text] [Related]
26. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820 [TBL] [Abstract][Full Text] [Related]
27. Phosphoproteomic analysis of protein kinase C signaling in Saccharomyces cerevisiae reveals Slt2 mitogen-activated protein kinase (MAPK)-dependent phosphorylation of eisosome core components. Mascaraque V; Hernáez ML; Jiménez-Sánchez M; Hansen R; Gil C; Martín H; Cid VJ; Molina M Mol Cell Proteomics; 2013 Mar; 12(3):557-74. PubMed ID: 23221999 [TBL] [Abstract][Full Text] [Related]
28. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644 [TBL] [Abstract][Full Text] [Related]
29. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells. Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687 [TBL] [Abstract][Full Text] [Related]
30. A pilot characterization of human lung NSCLC by protein pathway activation mapping. Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546 [TBL] [Abstract][Full Text] [Related]
31. Robust co-regulation of tyrosine phosphorylation sites on proteins reveals novel protein interactions. Naegle KM; White FM; Lauffenburger DA; Yaffe MB Mol Biosyst; 2012 Oct; 8(10):2771-82. PubMed ID: 22851037 [TBL] [Abstract][Full Text] [Related]
32. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition. Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103 [TBL] [Abstract][Full Text] [Related]
33. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma. Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563 [TBL] [Abstract][Full Text] [Related]
34. In Vitro Kinase-to-Phosphosite Database (iKiP-DB) Predicts Kinase Activity in Phosphoproteomic Datasets. Mari T; Mösbauer K; Wyler E; Landthaler M; Drosten C; Selbach M J Proteome Res; 2022 Jun; 21(6):1575-1587. PubMed ID: 35608653 [TBL] [Abstract][Full Text] [Related]
35. Positive-unlabeled ensemble learning for kinase substrate prediction from dynamic phosphoproteomics data. Yang P; Humphrey SJ; James DE; Yang YH; Jothi R Bioinformatics; 2016 Jan; 32(2):252-9. PubMed ID: 26395771 [TBL] [Abstract][Full Text] [Related]
36. A predictive phosphorylation signature of lung cancer. Wu CJ; Cai T; Rikova K; Merberg D; Kasif S; Steffen M PLoS One; 2009 Nov; 4(11):e7994. PubMed ID: 19946374 [TBL] [Abstract][Full Text] [Related]
37. Large-scale models of signal propagation in human cells derived from discovery phosphoproteomic data. Terfve CD; Wilkes EH; Casado P; Cutillas PR; Saez-Rodriguez J Nat Commun; 2015 Sep; 6():8033. PubMed ID: 26354681 [TBL] [Abstract][Full Text] [Related]
38. Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Casado P; Alcolea MP; Iorio F; Rodríguez-Prados JC; Vanhaesebroeck B; Saez-Rodriguez J; Joel S; Cutillas PR Genome Biol; 2013 Apr; 14(4):R37. PubMed ID: 23628362 [TBL] [Abstract][Full Text] [Related]
39. DM-MOGA: a multi-objective optimization genetic algorithm for identifying disease modules of non-small cell lung cancer. Shang J; Zhu X; Sun Y; Li F; Kong X; Liu JX BMC Bioinformatics; 2023 Jan; 24(1):13. PubMed ID: 36624376 [TBL] [Abstract][Full Text] [Related]